Proteon Therapeutics Inc (PRTO) is near the top in its industry group according to InvestorsObserver. PRTO gets an overall rating of 66. That means it scores higher than 66 percent of stocks. Proteon Therapeutics Inc gets a 85 rank in the Biotechnology industry. Biotechnology is number 57 out of 148 industries.
Click Here to get the full Stock Score Report on Proteon Therapeutics Inc (PRTO) Stock.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Proteon Therapeutics Inc Stock Today?
Proteon Therapeutics Inc (PRTO) stock is trading at $0.66 as of 12:23 PM on Thursday, Jan 9, a gain of $0.01, or 1.49% from the previous closing price of $0.65. Volume today is above average. So far 2,322,049 shares have traded compared to average volume of 249,902 shares. The stock has traded between $0.64 and $0.96 so far today.
